MXPA03010601A - Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos. - Google Patents
Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos.Info
- Publication number
- MXPA03010601A MXPA03010601A MXPA03010601A MXPA03010601A MXPA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A
- Authority
- MX
- Mexico
- Prior art keywords
- methylamine
- derivatives
- medicament
- thiophen
- furan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invencion se refiere a derivados de C-furan-2-il-metilamina y C-tiofen-2-il-metilamina sustituidos de la formula general (I), procedimientos para su preparacion, medicamentos composiciones farmaceuticas conteniendolos, asi como su uso para la preparacion de analgesicos, para la preparacion de un anestesico local, de un antiarritmico, un antiemetico, un nootropico y/o de medicamento para el tratamiento y/o la prevencion de enfermedades cardiovasculares, de incontinencia urinaria, diarrea, prurito y/o inflamaciones y/o de un medicamento para el tratamiento de depresiones y/o de abuso de alcohol y/o de drogas y/o de medicamentos y/o de un medicamento para el aumento de alerta.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10125145A DE10125145A1 (de) | 2001-05-22 | 2001-05-22 | Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate |
PCT/EP2002/005542 WO2002094802A1 (de) | 2001-05-22 | 2002-05-21 | Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03010601A true MXPA03010601A (es) | 2004-03-09 |
Family
ID=7685874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03010601A MXPA03010601A (es) | 2001-05-22 | 2002-05-21 | Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos. |
Country Status (17)
Country | Link |
---|---|
US (2) | US6878740B2 (es) |
EP (1) | EP1392670B1 (es) |
JP (1) | JP2004532246A (es) |
AR (1) | AR035982A1 (es) |
AT (1) | ATE299873T1 (es) |
AU (1) | AU2002338989B2 (es) |
CA (1) | CA2448038C (es) |
DE (2) | DE10125145A1 (es) |
DK (1) | DK1392670T3 (es) |
ES (1) | ES2242869T3 (es) |
HU (1) | HUP0401162A3 (es) |
MX (1) | MXPA03010601A (es) |
PE (1) | PE20021099A1 (es) |
PL (1) | PL367535A1 (es) |
PT (1) | PT1392670E (es) |
SI (1) | SI1392670T1 (es) |
WO (1) | WO2002094802A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0302094D0 (en) * | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
GB0324269D0 (en) * | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
KR100553398B1 (ko) * | 2004-03-12 | 2006-02-16 | 한미약품 주식회사 | 티에노[3,2-c]피리딘 유도체의 제조 방법 및 이에사용되는 중간체 |
US8884034B2 (en) | 2009-07-08 | 2014-11-11 | Dermira (Canada), Inc. | TOFA analogs useful in treating dermatological disorders or conditions |
JP6397025B2 (ja) * | 2013-11-22 | 2018-09-26 | テバ ブランデッド ファーマシューティカル プロダクツ アール アンド ディー インコーポレイテッド | 吸引可能薬剤 |
EP3470404A1 (en) * | 2016-05-31 | 2019-04-17 | Industry Academic Cooperation Foundation, Hallym University | Five-membered heterocyclic derivative, method for producing same, and pharmaceutical composition comprising same |
CN112521357B (zh) * | 2020-08-31 | 2021-10-08 | 深圳瑞健生物科技有限公司 | 一种长效低成瘾性hnk衍生物及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3890445A (en) * | 1973-01-05 | 1975-06-17 | Richardson Merrell Inc | Lactamimide derivatives useful as hypoglycemic agents |
US3816457A (en) * | 1973-01-05 | 1974-06-11 | Richardson Merrell Inc | Lactamimide derivatives |
WO2001068816A1 (en) | 2000-03-13 | 2001-09-20 | Smithkline Beecham Corporation | Human histamine h3 gene variant-3 |
DE10012820A1 (de) * | 2000-03-16 | 2001-09-20 | Bayer Ag | Substituierte 1-Aryl-cyclopropylmethylamino-1,3,5-triazine |
DE10059864A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate |
-
2001
- 2001-05-22 DE DE10125145A patent/DE10125145A1/de not_active Withdrawn
-
2002
- 2002-05-17 AR ARP020101843A patent/AR035982A1/es not_active Application Discontinuation
- 2002-05-21 JP JP2002591475A patent/JP2004532246A/ja active Pending
- 2002-05-21 EP EP02743057A patent/EP1392670B1/de not_active Expired - Lifetime
- 2002-05-21 DE DE50203686T patent/DE50203686D1/de not_active Expired - Lifetime
- 2002-05-21 AT AT02743057T patent/ATE299873T1/de not_active IP Right Cessation
- 2002-05-21 MX MXPA03010601A patent/MXPA03010601A/es active IP Right Grant
- 2002-05-21 PL PL02367535A patent/PL367535A1/xx not_active Application Discontinuation
- 2002-05-21 ES ES02743057T patent/ES2242869T3/es not_active Expired - Lifetime
- 2002-05-21 PE PE2002000428A patent/PE20021099A1/es not_active Application Discontinuation
- 2002-05-21 CA CA2448038A patent/CA2448038C/en not_active Expired - Fee Related
- 2002-05-21 PT PT02743057T patent/PT1392670E/pt unknown
- 2002-05-21 DK DK02743057T patent/DK1392670T3/da active
- 2002-05-21 SI SI200230178T patent/SI1392670T1/sl unknown
- 2002-05-21 HU HU0401162A patent/HUP0401162A3/hu unknown
- 2002-05-21 WO PCT/EP2002/005542 patent/WO2002094802A1/de active IP Right Grant
- 2002-05-21 AU AU2002338989A patent/AU2002338989B2/en not_active Ceased
-
2003
- 2003-11-21 US US10/717,932 patent/US6878740B2/en not_active Expired - Fee Related
-
2005
- 2005-03-07 US US11/072,962 patent/US7317034B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE50203686D1 (en) | 2005-08-25 |
ATE299873T1 (de) | 2005-08-15 |
US20050148550A1 (en) | 2005-07-07 |
CA2448038A1 (en) | 2002-11-28 |
US7317034B2 (en) | 2008-01-08 |
HUP0401162A3 (en) | 2007-05-02 |
JP2004532246A (ja) | 2004-10-21 |
EP1392670B1 (de) | 2005-07-20 |
PE20021099A1 (es) | 2003-01-25 |
WO2002094802A1 (de) | 2002-11-28 |
US20040152734A1 (en) | 2004-08-05 |
AR035982A1 (es) | 2004-07-28 |
DE10125145A1 (de) | 2002-11-28 |
EP1392670A1 (de) | 2004-03-03 |
CA2448038C (en) | 2010-09-28 |
PL367535A1 (en) | 2005-02-21 |
PT1392670E (pt) | 2005-10-31 |
AU2002338989B2 (en) | 2007-06-07 |
DK1392670T3 (da) | 2005-08-08 |
SI1392670T1 (sl) | 2005-12-31 |
US6878740B2 (en) | 2005-04-12 |
HUP0401162A2 (hu) | 2004-10-28 |
ES2242869T3 (es) | 2005-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2088A (en) | Phenethanolamine derivatives for treatment of respiratory diseases | |
MY129422A (en) | Medicinal compounds | |
WO2004037768A3 (en) | Phenethanolamine derivatives | |
UA74346C2 (uk) | Похідні амінодикарбонових кислот, їх застосування та лікарський засіб | |
WO2004037807A3 (en) | Medicinal arylethanolamine compounds | |
WO2004037773A8 (en) | Phenethanolamine derivative for the treatment of respiratory diseases | |
MXPA04001307A (es) | Compuestos biciclicos aromaticos sustituidos con aminoalquilo, metodo para la produccion de los mismos y su uso como farmacos. | |
NZ516347A (en) | Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
MXPA03011515A (es) | Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos. | |
WO2001085212A3 (en) | Drug delivery systems for photodynamic therapy | |
SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
HK1068811A1 (en) | Substituted oxazolidinones for combinational therapy | |
WO2001019776A3 (de) | Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften | |
RS89804A (en) | Medicaments containing betamimetic drugs and a novel anticholinesterase drug | |
WO2002088100A3 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
BR0209276A (pt) | Uso da azitromicina para a preparação de um medicamento para tratamento de doenças inflamatórias não infecciosas | |
WO2001024783A3 (de) | Verwendung von (+)-tramadol, o-demethyltramadol bzw. (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol bzw. (+)-o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
MXPA03010601A (es) | Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos. | |
CA2433833A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
BR0210473A (pt) | Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias | |
AU5372199A (en) | Cyclopentabenzofuran derivatives and their use | |
WO2002064552A8 (en) | 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES | |
AU2003281193A1 (en) | Quinazoline derivatives for use in the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |